Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Impact of Post-Hematopoietic Cell Transplant (HCT) Survival on Cost-Effectiveness of CPX-351 Versus 7+3 in the Treatment of Therapy-Related AML or AML-MRC in the United States

Anuraag Kansal, PhD, Odette Reifsnider, Lora Todorova, Anna Coughlan, Kathleen F. Villa

Blood (2018) 132 (Supplement 1): 5837.

https://doi.org/10.1182/blood-2018-99-112252

Published: 2018

Journal Articles

Cost-Effectiveness of Defibrotide for the Treatment of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) with Multi-Organ Dysfunction (MOD) Post-Hematopoietic Stem Cell Transplantation (HSCT) in Canada

Jonathan Belsey, Eric Ngonga Kemadjou, Maya Isaila, Kathleen F. Villa

Blood (2018) 132 (Supplement 1): 4702.

https://doi.org/10.1182/blood-2018-99-111396

Published: 2018

Journal Articles

Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) with or without Multi-Organ Dysfunction (MOD) after Hematopoietic Stem Cell Transplantation (HSCT): Analysis of a Multicenter Chart Review

Tina Doede, MS, MBA, Anusha Viddam, Kathleen F. Villa, MS, Alison L. Hannah, MD, Charles H. Weaver, MD, William Tappe, MD

Blood (2016) 128 (22): 5756.

https://doi.org/10.1182/blood.V128.22.5756.5756

Published: 2016

Journal Articles

Stratification of Allogeneic Hematopoietic Cell Transplant By Risk of Developing Veno-Occlusive Disease: A Model for Assigning a Risk Score

Christopher Strouse, MD, Ying Zhang, Mei-Jie Zhang, PhD, Alyssa DiGilio, MS, Marcelo C. Pasquini, MD, Mary M. Horowitz, MD MS, Stephanie J. Lee, MD, Muthalagu Ramanathan, MD, Wichai Chinratanalab, MD, Alison W Loren, MD MS, Linda J. Burns, MD, Andrew Artz, MD, Kathleen F. Villa, MS, Wael Saber, MD MS

Blood (2016) 128 (22): 983.

https://doi.org/10.1182/blood.V128.22.983.983

Published: 2016

Journal Articles

Hospital Cost Associated with Veno-Occlusive Disease (VOD) in Patients with Hematopoietic Stem Cell Transplant (HSCT)

Christopher C. Dvorak, MD, Bijan Nejadnik, MD, Zhun Cao, PhD, Craig Lipkin, MS, Scott B. Robinson, MA, MPH, Kathleen F. Villa, MS

Blood (2015) 126 (23): 4452.

https://doi.org/10.1182/blood.V126.23.4452.4452

Published: 2015

Journal Articles

Costs of Hematopoietic Stem Cell Transplantation and Associated Conditioning Regimens

Tiffany P. Quock, PhD MS, Michael S. Broder, MD MSHS, Eunice Chang, PhD, Sheila R. Reddy, PhD MS, RPh, Sally Arai, MD, Rajni Agarwal-Hashmi, MD, Kathleen F. Villa, MS

Blood (2015) 126 (23): 3270.

https://doi.org/10.1182/blood.V126.23.3270.3270

Published: 2015

Journal Articles

A Model Estimating Indirect Costs of Premature Death Associated with Severe Hepatic Veno-Occlusive Disease (sVOD) Among Hematopoietic Stem Cell Transplant (HSCT) Patients in the United States (U.S.)

Tiffany P. Quock, PhD MS, Zheng-Yi Zhou, PhD, Byran Dai, MS, Wenxi Tang, MS, Kathleen F. Villa, MS

Blood (2015) 126 (23): 3273.

https://doi.org/10.1182/blood.V126.23.3273.3273

Published: 2015

Journal Articles

Incidence of Hepatic Veno-Occlusive Disease (VOD) in Premier Healthcare Database

Christopher C. Dvorak, MD, Bijan Nejadnik, MD, Zhun Cao, PhD, Craig Lipkin, MS, Scott B. Robinson, MA, MPH, Kathleen F. Villa, MS

Blood (2015) 126 (23): 3280.

https://doi.org/10.1182/blood.V126.23.3280.3280

Published: 2015

Journal Articles

Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease: An Analysis of Clinical Benefit As Determined By Number Needed to Treat (NNT) to Achieve Complete Response and to Improve Survival

Paul G. Richardson, Nancy A. Kernan, MD, Stephan A. Grupp, MD PhD, Paul L. Martin, MD PhD, Robert J. Soiffer, MD, Richard Martin, MBChB, B(MDSc, MRCGP, Alison L. Hannah, MD, Kathleen F. Villa, MS

Blood (2014) 124 (21): 2469.

https://doi.org/10.1182/blood.V124.21.2469.2469

Published: 2014

Journal Articles

Risk-Benefit Trade-Off of Pediatric-Inspired Versus Hyper-CVAD Protocols for Philadelphia Negative Acute Lymphocytic Leukemia (ALL) in Adolescents and Young Adults: A Modeling Analysis

Gregory F. Guzauskas, MSPH, PhD, Kathleen F. Villa, MS, Trudy F. Vanhove, MD PhD MBA, David L. Veenstra, PharmD, PhD

Blood (2014) 124 (21): 1281.

https://doi.org/10.1182/blood.V124.21.1281.1281

Published: 2014

NARROW

Impact of Post-Hematopoietic Cell Transplant (HCT) Survival on Cost-Effectiveness of CPX-351 Versus 7+3 in the Treatment of Therapy-Related AML or AML-MRC in the United States

Cost-Effectiveness of Defibrotide for the Treatment of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) with Multi-Organ Dysfunction (MOD) Post-Hematopoietic Stem Cell Transplantation (HSCT) in Canada

Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) with or without Multi-Organ Dysfunction (MOD) after Hematopoietic Stem Cell Transplantation (HSCT): Analysis of a Multicenter Chart Review

Stratification of Allogeneic Hematopoietic Cell Transplant By Risk of Developing Veno-Occlusive Disease: A Model for Assigning a Risk Score

Hospital Cost Associated with Veno-Occlusive Disease (VOD) in Patients with Hematopoietic Stem Cell Transplant (HSCT)

Costs of Hematopoietic Stem Cell Transplantation and Associated Conditioning Regimens

A Model Estimating Indirect Costs of Premature Death Associated with Severe Hepatic Veno-Occlusive Disease (sVOD) Among Hematopoietic Stem Cell Transplant (HSCT) Patients in the United States (U.S.)

Incidence of Hepatic Veno-Occlusive Disease (VOD) in Premier Healthcare Database

Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease: An Analysis of Clinical Benefit As Determined By Number Needed to Treat (NNT) to Achieve Complete Response and to Improve Survival

Risk-Benefit Trade-Off of Pediatric-Inspired Versus Hyper-CVAD Protocols for Philadelphia Negative Acute Lymphocytic Leukemia (ALL) in Adolescents and Young Adults: A Modeling Analysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only